Pharmacielo Financial Statements From 2010 to 2024
| PCLOF Stock | USD 0.05 0.0007 1.34% |
Check Pharmacielo financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharmacielo's main balance sheet or income statement drivers, such as , as well as many indicators such as . Pharmacielo financial statements analysis is a perfect complement when working with Pharmacielo Valuation or Volatility modules.
Pharmacielo |
Pharmacielo Company Return On Equity Analysis
Pharmacielo's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Pharmacielo Return On Equity | -0.98 |
Most of Pharmacielo's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharmacielo is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Pharmacielo has a Return On Equity of -0.9777. This is 95.92% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is notably higher than that of the company.
Pharmacielo Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pharmacielo's current stock value. Our valuation model uses many indicators to compare Pharmacielo value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pharmacielo competition to find correlations between indicators driving Pharmacielo's intrinsic value. More Info.Pharmacielo is regarded fourth in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pharmacielo's earnings, one of the primary drivers of an investment's value.About Pharmacielo Financial Statements
Pharmacielo stakeholders use historical fundamental indicators, such as Pharmacielo's revenue or net income, to determine how well the company is positioned to perform in the future. Although Pharmacielo investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pharmacielo's assets and liabilities are reflected in the revenues and expenses on Pharmacielo's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pharmacielo. Please read more on our technical analysis and fundamental analysis pages.
PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies in Canada and Colombia. Pharmacielo is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Pharmacielo Pink Sheet
Pharmacielo financial ratios help investors to determine whether Pharmacielo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmacielo with respect to the benefits of owning Pharmacielo security.